Total Payments
$808,016
2024 Payments
$215,555
Companies
58
Transactions
1,744
Medicare Patients
2,933
Medicare Billing
$204,633
Payment Breakdown by Category
Other$555,627 (68.8%)
Travel$156,319 (19.3%)
Consulting$51,031 (6.3%)
Food & Beverage$34,967 (4.3%)
Education$10,072 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $488,820 | 231 | 60.5% |
| Travel and Lodging | $156,319 | 637 | 19.3% |
| Consulting Fee | $51,031 | 37 | 6.3% |
| Honoraria | $40,042 | 26 | 5.0% |
| Food and Beverage | $34,967 | 784 | 4.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $26,765 | 17 | 3.3% |
| Education | $10,072 | 12 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $230,040 | 444 | $0 (2024) |
| GlaxoSmithKline, LLC. | $165,132 | 192 | $0 (2024) |
| Incyte Corporation | $85,221 | 241 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $65,191 | 102 | $0 (2024) |
| CTI BioPharma Corp. | $57,769 | 67 | $0 (2023) |
| SOBI, INC | $48,976 | 65 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $36,401 | 91 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $23,729 | 58 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $22,911 | 42 | $0 (2023) |
| Celgene Corporation | $17,900 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $215,555 | 461 | GlaxoSmithKline, LLC. ($82,299) |
| 2023 | $150,584 | 402 | Janssen Biotech, Inc. ($52,171) |
| 2022 | $303,369 | 582 | Janssen Biotech, Inc. ($115,798) |
| 2021 | $138,507 | 299 | Incyte Corporation ($41,321) |
All Payment Transactions
1,744 individual payment records from CMS Open Payments — Page 1 of 70
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | JAZZ PHARMACEUTICALS INC. | ZIIHERA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $936.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/19/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $1.77 | General |
| 12/18/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,880.00 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,440.00 | General |
| Category: Oncology | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,080.00 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Travel and Lodging | Cash or cash equivalent | $109.99 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | Cash or cash equivalent | $96.66 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Oncology | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $562.50 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $89.45 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $26.93 | General |
| Category: Hematology | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,880.00 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | SOBI, INC | VONJO (Drug) | Consulting Fee | Cash or cash equivalent | $975.22 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,115.00 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,692.00 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Oncology | ||||||
| 12/07/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $30.10 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/05/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Honoraria | Cash or cash equivalent | $922.50 | General |
| Category: Oncology | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Travel and Lodging | Cash or cash equivalent | $71.43 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | Cash or cash equivalent | $49.85 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $127.44 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,880.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,192 | 2,221 | $300,283 | $63,693 |
| 2022 | 14 | 908 | 1,934 | $282,485 | $60,728 |
| 2021 | 13 | 575 | 1,109 | $207,687 | $45,673 |
| 2020 | 3 | 258 | 540 | $187,298 | $34,539 |
Total Patients
2,933
Total Services
5,804
Medicare Billing
$204,633
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 497 | $182,896 | $38,446 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 108 | $27,000 | $5,211 | 19.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 216 | 408 | $26,112 | $4,195 | 16.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 216 | 444 | $8,880 | $3,705 | 41.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 209 | 423 | $15,228 | $3,199 | 21.0% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 28 | 28 | $14,644 | $3,042 | 20.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 22 | $10,912 | $2,505 | 23.0% |
| 85055 | Reticulated (young) platelet measurement | Office | 2023 | 15 | 33 | $4,719 | $1,156 | 24.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 42 | 50 | $3,000 | $668.00 | 22.3% |
| 83550 | Iron binding capacity | Office | 2023 | 42 | 50 | $1,750 | $428.50 | 24.5% |
| 83521 | Measurement of immunoglobulin light chains | Office | 2023 | 12 | 24 | $1,440 | $406.20 | 28.2% |
| 83540 | Iron level | Office | 2023 | 42 | 50 | $1,350 | $317.00 | 23.5% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 23 | 42 | $1,428 | $260.73 | 18.3% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2023 | 23 | 42 | $924.00 | $152.98 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 469 | $172,592 | $37,579 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 157 | $39,250 | $8,754 | 22.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 26 | $12,896 | $2,962 | 23.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 172 | 364 | $13,104 | $2,750 | 21.0% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2022 | 22 | 22 | $11,506 | $2,571 | 22.3% |
| 85055 | Reticulated (young) platelet measurement | Office | 2022 | 21 | 51 | $7,293 | $1,703 | 23.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 182 | 445 | $8,900 | $1,311 | 14.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 65 | 114 | $7,296 | $1,166 | 16.0% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 26 | 95 | $3,230 | $604.79 | 18.7% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 26 | 28 | $1,680 | $375.52 | 22.4% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2022 | 26 | 95 | $2,090 | $354.88 | 17.0% |
About Mark Davis, PA-C
Mark Davis, PA-C is a Physician Assistant healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679580435.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Davis, PA-C has received a total of $808,016 in payments from pharmaceutical and medical device companies, with $215,555 received in 2024. These payments were reported across 1,744 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($488,820).
As a Medicare-enrolled provider, Davis has provided services to 2,933 Medicare beneficiaries, totaling 5,804 services with total Medicare billing of $204,633. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant, Medical
- Location Fort Worth, TX
- Active Since 08/02/2006
- Last Updated 06/01/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1679580435
Products in Payments
- DARZALEX (Biological) $206,052
- OJJAARA (Drug) $86,583
- BLENREP (Biological) $78,147
- NINLARO (Drug) $64,983
- Vonjo (Drug) $57,769
- JAKAFI (Drug) $49,599
- VONJO (Drug) $48,766
- REBLOZYL (Biological) $40,964
- MONJUVI (Drug) $27,393
- Tavalisse (Drug) $22,885
- CALQUENCE (Drug) $21,892
- TECVAYLI (Biological) $20,574
- LIBTAYO (Biological) $16,838
- KRAZATI (Drug) $8,690
- Pomalyst (Drug) $6,892
- XPOVIO (Drug) $5,651
- TAZVERIK (Drug) $3,529
- CARVYKTI (Drug) $3,017
- Tazverik (Drug) $2,778
- Epkinly (Drug) $2,259
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Fort Worth
Mrs. Amanda Duck, Pa-C, PA-C
Physician Assistant — Payments: $43,147
Physician Assistant $43,147
Tara Hall, Pac, PAC
Physician Assistant — Payments: $33,242
Physician Assistant $33,242
Adam Bruntz, Pa-C, PA-C
Physician Assistant — Payments: $15,161
Physician Assistant $15,161
Jacob Torre, Pa-C, PA-C
Physician Assistant — Payments: $13,352
Physician Assistant $13,352
Sonya Tanna, Pa, PA
Physician Assistant — Payments: $11,843
Physician Assistant $11,843
Lauren Harr, Pa-C, PA-C
Physician Assistant — Payments: $11,404
Physician Assistant $11,404